Evidence map›Paper›PMID 35760302›Full record

ArticleThe Journal of infection2022

Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study.

Yue Yin, Xinjie Li, Chungen Qian, Bangning Cheng, Fengmin Lu, Tao Shen

Abstract readLetterComment
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Yue YinDepartment of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, China.
Xinjie LiDepartment of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, China.
Chungen QianPeking University - YHLO Joint Laboratory for Molecular Diagnostics of Infectious Diseases, Peking University, Beijing, China.
Bangning ChengPeking University - YHLO Joint Laboratory for Molecular Diagnostics of Infectious Diseases, Peking University, Beijing, China.
Fengmin LuDepartment of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, China.
Tao ShenDepartment of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, China. Electronic address: taoshen@hsc.pku.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntibodiesCOVID-19 VaccinesAntibodies, NeutralizingAntibodies, ViralFollow-Up StudiesHumansImmunization, SecondaryVaccines, InactivatedAntibodiesAntibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesVaccines, Inactivated

Identifiers

PMID35760302
PMCPMC9233874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.